НовостиBenzingaGuggenheim Maintains Buy on Damora Therapeutics, Raises Price Target to $60 Guggenheim Maintains Buy on Damora Therapeutics, Raises Price Target to $60 Benzinga 2026.09.25 13:04 (GMT+0) Открыть на Benzinga Другие новости